These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14748795)

  • 1. Abolish C3.
    Arif S; Singh N
    Cytopathology; 2004 Feb; 15(1):63-4. PubMed ID: 14748795
    [No Abstract]   [Full Text] [Related]  

  • 2. Abolish C3.
    Osin P
    Cytopathology; 2004 Feb; 15(1):64. PubMed ID: 14748796
    [No Abstract]   [Full Text] [Related]  

  • 3. Why abolish C3?
    Trott PA
    Cytopathology; 2003 Dec; 14(6):352. PubMed ID: 14632735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality assurance of fine-needle aspiration cytology of the organized mammography screening].
    Bak M; Konyár E; Schneider F; Bidlek M; Szabó E; Nyári T; Godény M; Kásler M
    Orv Hetil; 2010 Aug; 151(32):1295-8. PubMed ID: 20656669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why abolish C3?
    Al-Adnani M; Etessami N; Freeman A; Falzon M
    Cytopathology; 2003 Oct; 14(5):302-3. PubMed ID: 14510897
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assurance of predictive markers in breast cancer.
    Rhodes A; Barnes DM
    Methods Mol Med; 2004; 97():29-57. PubMed ID: 15064483
    [No Abstract]   [Full Text] [Related]  

  • 7. The advantage of combined fine needle aspiration cytology and imaging scores over fine needle aspiration cytology score alone in a breast screening program.
    Jones F; Holmes CE; Zardawi IM; Braye S
    Acta Cytol; 2010; 54(5):721-4. PubMed ID: 20968162
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of cytological categories atypical (C3) and suspected (C4) with histopathological diagnoses of breast lesions.
    Vuckovic L; Crnogorac N; Panjkovic M; Miladinovic M; Vuksanovic-Bozaric A; Filipovic A; Matic S; Jancic S
    J BUON; 2018; 23(2):366-371. PubMed ID: 29745078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value of breast fine needle aspiration cytology (FNAC) in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology.
    Bulgaresi P; Cariaggi P; Ciatto S; Houssami N
    Breast Cancer Res Treat; 2006 Jun; 97(3):319-21. PubMed ID: 16570117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fine needle aspiration cytology of mammography screening].
    Engvad B; Laenkholm AV; Schwartz W; Bak M
    Ugeskr Laeger; 2009 Aug; 171(34):2379-82. PubMed ID: 19732519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer--screening data for assessing quality of services--New York, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(21):455-7. PubMed ID: 15175570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytohistopathological correlation of C3 and C4 breast lesions.
    Zafar N; Jamal S; Mamoon N; Luqman M
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):196-9. PubMed ID: 15857588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical efficacy of minimally invasive procedures for breast cancer screening at a teaching hospital.
    Verenhitach BD; Elias S; Patrocínio AC; Nazário AC; Waizberg A
    J Clin Pathol; 2011 Oct; 64(10):858-61. PubMed ID: 21666140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of "equivocal" (C3) and "suspicious" (C4) categories in fine needle aspiration cytology of the breast.
    Deb RA; Matthews P; Elston CW; Ellis IO; Pinder SE
    Cytopathology; 2001 Aug; 12(4):219-26. PubMed ID: 11488870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of fine needle aspiration versus core needle biopsy in clinically palpable breast lesions: a report on the predictive values and a cost comparison.
    Nagar S; Iacco A; Riggs T; Kestenberg W; Keidan R
    Am J Surg; 2012 Aug; 204(2):193-8. PubMed ID: 22464444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical guidelines for the management of breast cancer.
    Association of Breast Surgery at Baso 2009
    Eur J Surg Oncol; 2009; 35 Suppl 1():1-22. PubMed ID: 19299100
    [No Abstract]   [Full Text] [Related]  

  • 17. The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.
    Field AS; Raymond WA; Rickard M; Arnold L; Brachtel EF; Chaiwun B; Chen L; Di Bonito L; Kurtycz DFI; Lee AHS; Lim E; Ljung BM; Michelow P; Osamura RY; Pinamonti M; Sauer T; Segara D; Tse G; Vielh P; Chong PY; Schmitt F
    Acta Cytol; 2019; 63(4):257-273. PubMed ID: 31112942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of accuracy in breast cytology.
    Singh N; Wells CA
    Cytopathology; 2001 Aug; 12(4):211-8. PubMed ID: 11488869
    [No Abstract]   [Full Text] [Related]  

  • 19. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation.
    Wong S; Rickard M; Earls P; Arnold L; Bako B; Field AS
    Acta Cytol; 2019; 63(4):280-291. PubMed ID: 31108486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.